Integrated Diagnostics HoldingsLSE:IDHC +0.40%58 PB Ratio is 4.11 as of Jun. 26, 2026, which is 1% above its 10-year median of 4.06. GuruFocus rates LSE:IDHC with a GF Score™ of 58/100 and a GF Value™ of $0.57 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 196 Medical Diagnostics & Research companies, Integrated Diagnostics Holdings ranks worse than 75% on this metric.
Integrated Diagnostics Holdings PLC stock PB Ratio (=4.66) is close to 1-year low of 4.45.
The historical rank and industry rank for Integrated Diagnostics Holdings's PB Ratio or its related term are showing as below:
LSE:IDHC'
s PB Ratio Range Over the Past 10 Years
Min: 2.08 Med: 4.06 Max: 6.68
Current: 4.12
During the past 13 years, Integrated Diagnostics Holdings's highest PB Ratio was 6.68. The lowest was 2.08. And the median was 4.06.
LSE:IDHC's PB Ratio is ranked worse than 75% of 196
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.05
vs LSE:IDHC: 4.12
During the past 12 months, Integrated Diagnostics Holdings's average Book Value Per Share Growth Rate was 23.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -5.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -17.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -9.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Integrated Diagnostics Holdings was 9.10% per year. The lowest was -30.50% per year. And the median was -14.10% per year.
Back to Basics: PB Ratio
Integrated Diagnostics Holdings (LSE:IDHC) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Integrated Diagnostics Holdings PB Ratio Related Terms
Integrated Diagnostics Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrated Diagnostics Holdings PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Integrated Diagnostics Holdings's PB Ratio falls into.
Integrated Diagnostics Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Integrated Diagnostics Holdings (LSE:IDHC) has a PB Ratio of 4.11 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Integrated Diagnostics Holdings and its competitors. This is near median its historical median of 4.06. Over the past decade, Integrated Diagnostics Holdings' PB Ratio has ranged from 2.08 to 6.68. According to the industry distribution chart, Integrated Diagnostics Holdings ranks #147 out of 196 companies in the Medical Diagnostics & Research industry, placing it in the top 75%.
Is Integrated Diagnostics Holdings' PB Ratio too high?
Integrated Diagnostics Holdings' current PB Ratio of 4.11 is near median its 10-year median of 4.06. Over the past 10 years, this metric has ranged from a low of 2.08 to a high of 6.68. The Medical Diagnostics & Research industry median PB Ratio is 2.05. Integrated Diagnostics Holdings' value of 4.11 is 100.5% above this industry median. Based on the distribution chart, Integrated Diagnostics Holdings ranks #147 out of 196 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Integrated Diagnostics Holdings has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integrated Diagnostics Holdings' PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Integrated Diagnostics Holdings ranks #147 out of 196 companies for PB Ratio. This places Integrated Diagnostics Holdings in the lower half of its industry. The industry median PB Ratio is 2.05. Integrated Diagnostics Holdings' value of 4.11 is 100.5% above this benchmark. Historically, Integrated Diagnostics Holdings' own PB Ratio has ranged from 2.08 to 6.68 over the past decade. While the company's 10-year median is 4.06 vs. the industry median of 2.05, Integrated Diagnostics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.05, based on 196 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrated Diagnostics Holdings's current PB Ratio of 4.11 is 100.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Integrated Diagnostics Holdings and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrated Diagnostics Holdings's current PB Ratio is 4.11, which is near median its own 10-year median of 4.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings (LSE:IDHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.57, compared to a current price of $0.50 — trading 11.9% below its estimated fair value. The current PB Ratio is 4.11, which is near median its 10-year median of 4.06 and 100.5% above the Medical Diagnostics & Research industry median of 2.05. Integrated Diagnostics Holdings' overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Integrated Diagnostics Holdings (LSE:IDHC), the current PB Ratio is 4.11 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrated Diagnostics Holdings (LSE:IDHC) Overvalued in 2026?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings stock appears to be undervalued.
The current stock price of $0.50 is trading 11.9% below its estimated GF Value™ of $0.57.
GuruFocus considers Integrated Diagnostics Holdings to be Modestly Undervalued.
Key valuation signals for LSE:IDHC:
PB Ratio: 4.11 (near median its 10-year median of 4.06)
GF Value™: $0.57 vs. price of $0.50 (11.9% below fair value)
Industry Position: 100.5% above the Medical Diagnostics & Research median (#147 of 196)
No single metric tells the full story. See the LSE:IDHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrated Diagnostics Holdings Business Description
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
58GF Score
Get the complete analysis for LSE:IDHC
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IDHC has been successfully added to your 
